ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GEORGE STOICA M.D.

Internal Medicine

513

$80.8K

71
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

67%
prescriptions for brand name drugs

Avg: 25%

$158
Average prescription price

Avg: $56

JOSE JOY COLON MD

Internal Medicine

514

$23.6K

75
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $56

HARDESH GARG M.D

Internal Medicine

514

$14.9K

49
0 are 65+

84%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$29
Average prescription price

Avg: $56

JORGE LALOMA-SANCHEZ M.D.

Internal Medicine

516

$45.1K

81
26 are 65+

69%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$87
Average prescription price

Avg: $56

MEGAN SPENCER M.D.

Internal Medicine

517

$23.3K

55
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

MARYAM QADIR MD

Internal Medicine

519

$55.7K

82
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$107
Average prescription price

Avg: $56

JEFFERSON HERRING MD

Internal Medicine

524

$31.4K

59
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

GEORGE ANDRICOPOULOS M.D.

Internal Medicine

526

$26.3K

63
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $56

ROBERT ZAIDEN M.D.

Internal Medicine

527

$415K

111
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$788
Average prescription price

Avg: $56

CARLOS RODRIGUEZ M.D.

Internal Medicine

528

$8,587

284
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $56

OMAR CARDENAS M.D.

Internal Medicine

529

$14.9K

171
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$28
Average prescription price

Avg: $56

SCOTT WHITTIER M.D.

Internal Medicine

529

$7,851

295
176 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 25%

$15
Average prescription price

Avg: $56

RONALD LEE M.D.

Internal Medicine

533

$61.2K

140
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $56

ERIKA BRADSHAW M.D.

Internal Medicine

533

$37.3K

86
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $56

REYNALD ALLAM MD

Internal Medicine

534

$84.8K

162
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$159
Average prescription price

Avg: $56

CARL GITTENS M.D.

Internal Medicine

539

$22.5K

23
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

52%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $56

SURYANARAYANA SUNKAVALLI MD

Internal Medicine

542

$19.7K

73
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$36
Average prescription price

Avg: $56

MARTIN ROBERTS MD

Internal Medicine

544

$17.1K

160
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $56

DANIEL KAPLAN MD

Internal Medicine

550

$30.7K

53
20 are 65+

68%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

ERIC ROSENBERG MD

Internal Medicine

551

$30.7K

60
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

ALY SHERALY MD

Internal Medicine

551

$33K

148
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

REBECCA PAULY MD

Internal Medicine

559

$37.1K

35
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

GLORIA RYAN M.D.

Internal Medicine

559

$207K

50
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 25%

$370
Average prescription price

Avg: $56

BENNETT LEWIS

Internal Medicine

560

$41.1K

60
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$73
Average prescription price

Avg: $56

RUBEN HERNANDEZ M.D.

Internal Medicine

560

$15.9K

115
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 25%

$28
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank